ArticleCell death & disease2022

HN1L/AP-2γ/PLK1 signaling drives tumor progression and chemotherapy resistance in esophageal squamous cell carcinoma.

Ting-Ting Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.